Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Korean Health Ministry's New Pricing System Draws Industry Criticism

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry of Health and Welfare held a two-day forum offering a rare opportunity for Korean and foreign pharmaceutical officials to offer comments on the ministry's controversial new pricing system

You may also be interested in...

Korea Health Ministry Committee Approves New Price-Volume Formula For Drugs Over Industry Opposition

A new price-volume formula in Korea could lead to additional price cuts on blockbuster medications and lead to some compounds not being listed for government reimbursement after implementation next year.

South Korea Mulls Revision Of Price Volume Agreement, Stoking Opposition Across Industry

Industry expects proposed price volume agreement revisions would cut prices for drugs that exceed year-on-year sales increases of only $4.4 million.

Korea Extends Closely Watched Pilot Project For Rare Disease Drug Refunds Three More Years

To maintain a stable supply of some multinational products for patients with rare diseases, the health ministry has extended its pilot refund system for three more years until 2015.

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts